Loading...

Lieberman Jay

TitleDirector
InstitutionUniversity of California Los Angeles
DepartmentAvascular Necrosis
Address76-134 CHS
CAMPUS - 690218
Phone(310) 825-7687
vCardDownload vCard
    Other Positions
    TitleProfessor


    Collapse Research 
    Collapse Research Activities and Funding
    Regional Gene Therapy to Enhance Bone Repair
    NIH/NIAMS R01AR057076Apr 1, 2010 - Mar 31, 2022
    Role: Principal Investigator
    RANKL and BMPs in Prostate Cancer Induced Bone Lesions
    NIH/NCI R01CA103039Sep 1, 2003 - Jun 30, 2009
    Role: Principal Investigator
    Regional Gene Therapy to Enhance Bone Repair
    NIH/NIAMS R01AR046789Apr 1, 2001 - Jan 31, 2005
    Role: Principal Investigator
    RECOMBINANT BMP AND BONE FORMATION
    NIH/NIAMS K11AR001931Sep 30, 1994 - Aug 31, 1999
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bougioukli S, Sugiyama O, Alluri RK, Yoho R, Oakes DA, Lieberman J. In vitro evaluation of a lentiviral two-step transcriptional amplification system using GAL4FF transactivator for gene therapy applications in bone repair. Gene Ther. 2018 Jun 15. PMID: 29907876.
      View in: PubMed
    2. Halawi MJ, Lieberman J. Opioids in Total Joint Arthroplasty: Moving Forward. J Arthroplasty. 2018 Jun 07. PMID: 29903460.
      View in: PubMed
    3. Conaghan PG, Hunter DJ, Cohen SB, Kraus VB, Berenbaum F, Lieberman J, Jones DG, Spitzer AI, Jevsevar DS, Katz NP, Burgess DJ, Lufkin J, Johnson JR, Bodick N. Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study. J Bone Joint Surg Am. 2018 Apr 18; 100(8):666-677. PMID: 29664853.
      View in: PubMed
    4. Lieberman J, Molloy RM, Springer BD. Practice Management Strategies Among Current Members of the American Association of Hip and Knee Surgeons. J Arthroplasty. 2018 Apr 10. PMID: 29731268.
      View in: PubMed
    5. Bougioukli S, Evans C, Alluri R, Ghivizzani S, Lieberman J. Gene Therapy to Enhance Bone and Cartilage Repair in Orthopaedic Surgery. Curr Gene Ther. 2018 Apr 10. PMID: 29637858.
      View in: PubMed
    6. Lieberman J. Deep Vein Thrombosis Prophylaxis: State of the Art. J Arthroplasty. 2018 Mar 21. PMID: 29573919.
      View in: PubMed
    7. Bougioukli S, Sugiyama O, Pannell W, Ortega B, Tan MH, Tang AH, Yoho R, Oakes DA, Lieberman J. Gene Therapy for Bone Repair Using Human Cells: Superior Osteogenic Potential of Bone Morphogenetic Protein 2-Transduced Mesenchymal Stem Cells Derived from Adipose Tissue Compared to Bone Marrow. Hum Gene Ther. 2018 Apr; 29(4):507-519. PMID: 29212377.
      View in: PubMed
    8. Alluri R, Jakus A, Bougioukli S, Pannell W, Sugiyama O, Tang A, Shah R, Lieberman J. 3D printed hyperelastic "bone" scaffolds and regional gene therapy: A novel approach to bone healing. J Biomed Mater Res A. 2018 Apr; 106(4):1104-1110. PMID: 29266747.
      View in: PubMed
    9. Heckmann ND, Sivasundaram L, Stefl MD, Kang HP, Basler ET, Lieberman J. Total Hip Arthroplasty Bearing Surface Trends in the United States From 2007 to 2014: The Rise of Ceramic on Polyethylene. J Arthroplasty. 2018 Jan 09. PMID: 29429883.
      View in: PubMed
    10. Bramos A, Perrault DP, Fedenko AN, Kim GH, Bougioukli S, Lieberman J, Calvert JW, Wong AK. Porcine Mesothelium-Wrapped Diced Cartilage Grafts for Nasal Reconstruction. Tissue Eng Part A. 2018 Apr; 24(7-8):672-681. PMID: 28922982.
      View in: PubMed
    11. Lieberman J, Heckmann N. Venous Thromboembolism Prophylaxis in Total Hip Arthroplasty and Total Knee Arthroplasty Patients: From Guidelines to Practice. J Am Acad Orthop Surg. 2017 Dec; 25(12):789-798. PMID: 29176502.
      View in: PubMed
    12. Cote MP, Chen A, Jiang Y, Cheng V, Lieberman J. Persistent Pulmonary Embolism Rates Following Total Knee Arthroplasty Even With Prophylactic Anticoagulants. J Arthroplasty. 2017 Dec; 32(12):3833-3839. PMID: 28807470.
      View in: PubMed
    13. He X, Bougioukli S, Ortega B, Arevalo E, Lieberman J, McMahon AP. Sox9 positive periosteal cells in fracture repair of the adult mammalian long bone. Bone. 2017 Oct; 103:12-19. PMID: 28627474.
      View in: PubMed
    14. Bradley AT, Cohen JR, Lieberman J. Preoperative Interventions and Charges in the 2-Year Period Before Unicompartmental Knee Arthroplasty: What Happens Before Surgery. J Arthroplasty. 2017 Nov; 32(11):3298-3303.e6. PMID: 28648710.
      View in: PubMed
    15. Lieberman J, Pannell W, Trousdale RT, Mason JB, Callaghan JJ. Primary Total Hip Arthroplasty: Everything You Need to Know. Instr Course Lect. 2017 Feb 15; 66:165-179. PMID: 28594496.
      View in: PubMed
    16. Lieberman J, Cheng V, Cote MP. Pulmonary Embolism Rates Following Total Hip Arthroplasty With Prophylactic Anticoagulation: Some Pulmonary Emboli Cannot Be Avoided. J Arthroplasty. 2017 03; 32(3):980-986. PMID: 27866948.
      View in: PubMed
    17. Cohen JR, Bradley AT, Lieberman J. Preoperative Interventions and Charges Before Total Knee Arthroplasty. J Arthroplasty. 2016 12; 31(12):2730-2735.e7. PMID: 27394074.
      View in: PubMed
    18. Lieberman J, Polkowski GG, Della Valle CJ. Practice Management Strategies Among Current Members of the American Association of Hip and Knee Surgeons. J Arthroplasty. 2016 09; 31(9 Suppl):3-6. PMID: 27236744.
      View in: PubMed
    19. Lieberman J. American Association of Hip and Knee Surgeons and Outcome Measures After Total Joint Arthroplasty. J Arthroplasty. 2016 06; 31(6):1137-8. PMID: 27215138.
      View in: PubMed
    20. Bohl DD, Maltenfort MG, Huang R, Parvizi J, Lieberman J, Della Valle CJ. Development and Validation of a Risk Stratification System for Pulmonary Embolism After Elective Primary Total Joint Arthroplasty. J Arthroplasty. 2016 09; 31(9 Suppl):187-91. PMID: 27067463.
      View in: PubMed
    21. Bougioukli S, Jain A, Sugiyama O, Tinsley BA, Tang AH, Tan MH, Adams DJ, Kostenuik PJ, Lieberman J. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. Bone. 2016 Mar; 84:93-103. PMID: 26723577.
      View in: PubMed
    22. Tinsley BA, Dukas A, Pensak MJ, Adams DJ, Tang AH, Ominsky MS, Ke HZ, Lieberman J. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model. J Bone Joint Surg Am. 2015 Nov 18; 97(22):1852-9. PMID: 26582615.
      View in: PubMed
    23. Meneghini RM, Hull JR, Russo GS, Lieberman J, Jiranek WA. Porous Tantalum Buttress Augments for Severe Acetabular Posterior Column Deficiency. Surg Technol Int. 2015 Nov; 27:240-4. PMID: 26680404.
      View in: PubMed
    24. Lieberman J. Editorial. J Arthroplasty. 2015 Nov; 30(11):1859. PMID: 26548522.
      View in: PubMed
    25. Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman J. Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A Ten-Year Update. J Bone Joint Surg Am. 2015 Oct 07; 97(19):1604-27. PMID: 26446969.
      View in: PubMed
    26. Heckmann N, Sivasundaram L, Lieberman J. Propionibacterium acnes Infection in the Native Hip: A Case Report. JBJS Case Connect. 2015 Jul-Sep; 5(3):e60. PMID: 29252848.
      View in: PubMed
    27. Pierce TP, Cherian JJ, Jauregui JJ, Elmallah RK, Lieberman J, Mont MA. A Current Review of Mechanical Compression and Its Role in Venous Thromboembolic Prophylaxis in Total Knee and Total Hip Arthroplasty. J Arthroplasty. 2015 Dec; 30(12):2279-84. PMID: 26048728.
      View in: PubMed
    28. Stavrakis AI, SooHoo NF, Lieberman J. In Reply to Letter to the Editor "Bilateral Total Hip Arthroplasty has Similar Complication Rates to Unilateral Total Hip Arthroplasty". J Arthroplasty. 2015 Oct; 30(10):1856-7. PMID: 26031690.
      View in: PubMed
    29. Stavrakis AI, SooHoo NF, Lieberman J. Bilateral Total Hip Arthroplasty has Similar Complication Rates to Unilateral Total Hip Arthroplasty. J Arthroplasty. 2015 Jul; 30(7):1211-4. PMID: 25737389.
      View in: PubMed
    30. van der Jagt D, Mokete L, Pietrzak J, Zalavras CG, Lieberman J. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2015 Feb; 23(2):69-70. PMID: 25624358.
      View in: PubMed
    31. Lanting BA, Lieberman J, Callaghan JJ, Berend ME, MacDonald SJ. Ensuring a Winner: The ABCs of Primary Total Knee Arthroplasty. Instr Course Lect. 2015; 64:369-79. PMID: 25745921.
      View in: PubMed
    32. Zalavras CG, Lieberman J. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2014 Jul; 22(7):455-64. PMID: 24966252.
      View in: PubMed
    33. Alaee F, Hong SH, Dukas AG, Pensak MJ, Rowe DW, Lieberman J. Evaluation of osteogenic cell differentiation in response to bone morphogenetic protein or demineralized bone matrix in a critical sized defect model using GFP reporter mice. J Orthop Res. 2014 Sep; 32(9):1120-8. PMID: 24888702.
      View in: PubMed
    34. Bozic KJ, Grosso LM, Lin Z, Parzynski CS, Suter LG, Krumholz HM, Lieberman J, Berry DJ, Bucholz R, Han L, Rapp MT, Bernheim S, Drye EE. Variation in hospital-level risk-standardized complication rates following elective primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2014 Apr 16; 96(8):640-7. PMID: 24740660.
      View in: PubMed
    35. Van Citters AD, Fahlman C, Goldmann DA, Lieberman J, Koenig KM, DiGioia AM, O'Donnell B, Martin J, Federico FA, Bankowitz RA, Nelson EC, Bozic KJ. Developing a pathway for high-value, patient-centered total joint arthroplasty. Clin Orthop Relat Res. 2014 May; 472(5):1619-35. PMID: 24297106; PMCID: PMC3971244.
    36. Alaee F, Virk MS, Tang H, Sugiyama O, Adams DJ, Stolina M, Dwyer D, Ominsky MS, Ke HZ, Lieberman J. Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat femoral defect model. J Orthop Res. 2014 Feb; 32(2):197-203. PMID: 24600701.
      View in: PubMed
    37. Lieberman J, Engstrom SM, Solovyova O, Au C, Grady JJ. Is intra-articular hyaluronic acid effective in treating osteoarthritis of the hip joint? J Arthroplasty. 2015 Mar; 30(3):507-11. PMID: 25542833.
      View in: PubMed
    38. Lieberman J, Pensak MJ. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2013 Oct 02; 95(19):1801-11. PMID: 24088973.
      View in: PubMed
    39. Meneghini RM, Russo GS, Lieberman J. Modern perceptions and expectations regarding total knee arthroplasty. J Knee Surg. 2014 Apr; 27(2):93-7. PMID: 23775544.
      View in: PubMed
    40. Lieberman J, Varthi AG, Polkowski GG. Osteonecrosis of the knee - which joint preservation procedures work? J Arthroplasty. 2014 Jan; 29(1):52-6. PMID: 23725928.
      View in: PubMed
    41. Meneghini RM, Daluga AT, Sturgis LA, Lieberman J. Is the pie-crusting technique safe for MCL release in varus deformity correction in total knee arthroplasty? J Arthroplasty. 2013 Sep; 28(8):1306-9. PMID: 23680500.
      View in: PubMed
    42. Virk MS, Alaee F, Tang H, Ominsky MS, Ke HZ, Lieberman J. Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model. J Bone Joint Surg Am. 2013 Apr 17; 95(8):694-701. PMID: 23595067; PMCID: PMC3748979.
    43. SooHoo NF, Farng E, Chambers L, Znigmond DS, Lieberman J. Comparison of complication rates between hemiarthroplasty and total hip arthroplasty for intracapsular hip fractures. Orthopedics. 2013 Apr; 36(4):e384-9. PMID: 23590773.
      View in: PubMed
    44. Lieberman J, Pensak MJ, Kelleher MS, Leger RR, Polkowski GG. Disclosure of financial conflicts of interest: an evaluation of orthopaedic surgery patients' understanding. Clin Orthop Relat Res. 2013 Feb; 471(2):472-7. PMID: 22948521; PMCID: PMC3549175.
    45. Pensak MJ, Lieberman J. Gene therapy for bone regeneration. Curr Pharm Des. 2013; 19(19):3466-73. PMID: 23432674.
      View in: PubMed
    46. Soung do Y, Talebian L, Matheny CJ, Guzzo R, Speck ME, Lieberman J, Speck NA, Drissi H. Runx1 dose-dependently regulates endochondral ossification during skeletal development and fracture healing. J Bone Miner Res. 2012 Jul; 27(7):1585-97. PMID: 22431360; PMCID: PMC3377839.
    47. Preventing venous thromboembolic disease in patients undergoing elective total hip and knee arthroplasty. J Bone Joint Surg Am. 2012 Apr 18; 94(8):673-4. PMID: 22517384; PMCID: PMC3326687.
    48. Lieberman J, Freiberg AA, Lavernia CJ. Practice management strategies among members of the American Association of Hip and Knee Surgeons. J Arthroplasty. 2012 Sep; 27(8 Suppl):17-9.e1-6. PMID: 22503334.
      View in: PubMed
    49. Lieberman J, Engstrom SM, Meneghini RM, SooHoo NF. Which factors influence preservation of the osteonecrotic femoral head? Clin Orthop Relat Res. 2012 Feb; 470(2):525-34. PMID: 21879405; PMCID: PMC3254748.
    50. Dalury DF, Lieberman J, Macdonald SJ. Current and innovative pain management techniques in total knee arthroplasty. Instr Course Lect. 2012; 61:383-8. PMID: 22301246.
      View in: PubMed
    51. Lieberman J. The new AAOS clinical practice guidelines on venous thromboembolic prophylaxis: how to adapt them to your practice. J Am Acad Orthop Surg. 2011 Dec; 19(12):717-21. PMID: 22134203.
      View in: PubMed
    52. Lieberman J. Hybrid and cementless total hip replacements in patients younger than fifty years of age were similar after eighteen years. J Bone Joint Surg Am. 2011 Nov 16; 93(22):2123. PMID: 22262385.
      View in: PubMed
    53. Anderson FA, Huang W, Friedman RJ, Kwong LM, Lieberman J, Pellegrini VD. Prevention of venous thromboembolism after hip or knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons. J Arthroplasty. 2012 May; 27(5):659-66.e5. PMID: 22035977.
      View in: PubMed
    54. Dalury DF, Lieberman J, MacDonald SJ. Current and innovative pain management techniques in total knee arthroplasty. J Bone Joint Surg Am. 2011 Oct 19; 93(20):1938-43. PMID: 22012532.
      View in: PubMed
    55. Lieberman J, Leger RR, Tao JC, Clohisy JC, Meneghini RM. Total hip arthroplasty surveillance: when do we see our patients postoperatively? J Arthroplasty. 2011 Dec; 26(8):1161-4. PMID: 21802255.
      View in: PubMed
    56. Alaee F, Sugiyama O, Virk MS, Tang Y, Wang B, Lieberman J. In vitro evaluation of a double-stranded self-complementary adeno-associated virus type2 vector in bone marrow stromal cells for bone healing. Genet Vaccines Ther. 2011 Feb 27; 9:4. PMID: 21352585; PMCID: PMC3056728.
    57. Virk MS, Alaee F, Petrigliano FA, Sugiyama O, Chatziioannou AF, Stout D, Dougall WC, Lieberman J. Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion. Bone. 2011 Mar 01; 48(3):578-87. PMID: 21073986; PMCID: PMC3039095.
    58. Bernthal NM, Stavrakis AI, Billi F, Cho JS, Kremen TJ, Simon SI, Cheung AL, Finerman GA, Lieberman J, Adams JS, Miller LS. A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One. 2010 Sep 07; 5(9):e12580. PMID: 20830204; PMCID: PMC2935351.
    59. Soohoo NF, Farng E, Lieberman J, Chambers L, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res. 2010 Sep; 468(9):2363-71. PMID: 20428982; PMCID: PMC2914297.
    60. Sheth NP, Lieberman J, Della Valle CJ. DVT prophylaxis in total joint reconstruction. Orthop Clin North Am. 2010 Apr; 41(2):273-80. PMID: 20399366.
      View in: PubMed
    61. Petrigliano FA, Virk MS, Liu N, Sugiyama O, Yu D, Lieberman J. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter. Prostate. 2009 Sep 15; 69(13):1422-34. PMID: 19489029.
      View in: PubMed
    62. Lieberman J, Barnes CL, Lachiewicz PF, Hanssen AD, Clarke HD, Pellegrini VD. Venous thromboembolism debate in joint arthroplasty. J Bone Joint Surg Am. 2009 Aug; 91 Suppl 5:29-32. PMID: 19648620.
      View in: PubMed
    63. Johanson NA, Lachiewicz PF, Lieberman J, Lotke PA, Parvizi J, Pellegrini V, Stringer TA, Tornetta P, Haralson RH, Watters WC. American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am. 2009 Jul; 91(7):1756-7. PMID: 19571100.
      View in: PubMed
    64. Cuomo AV, Virk M, Petrigliano F, Morgan EF, Lieberman J. Mesenchymal stem cell concentration and bone repair: potential pitfalls from bench to bedside. J Bone Joint Surg Am. 2009 May; 91(5):1073-83. PMID: 19411455.
      View in: PubMed
    65. Johanson NA, Lachiewicz PF, Lieberman J, Lotke PA, Parvizi J, Pellegrini V, Stringer TA, Tornetta P, Haralson RH, Watters WC. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg. 2009 Mar; 17(3):183-96. PMID: 19264711.
      View in: PubMed
    66. Lieberman J. Medial-wedge insoles improved pain and function in osteoarthritic knees with valgus deformity. J Bone Joint Surg Am. 2009 Feb; 91(2):493. PMID: 19182007.
      View in: PubMed
    67. Lieberman J. Two alternative bearings for total hip arthroplasty: more data are needed. J Am Acad Orthop Surg. 2009 Feb; 17(2):61-2. PMID: 19202118.
      View in: PubMed
    68. Soohoo NF, Lieberman J, Farng E, Park S, Jain S, Ko CY. Perioperative quality-of-care measures for patients undergoing total hip or total knee replacement. J Long Term Eff Med Implants. 2009; 19(4):249-53. PMID: 21083530.
      View in: PubMed
    69. Virk MS, Petrigliano FA, Liu NQ, Chatziioannou AF, Stout D, Kang CO, Dougall WC, Lieberman J. Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone. Bone. 2009 Jan; 44(1):160-7. PMID: 18929692; PMCID: PMC2657045.
    70. Pianta TJ, Lieberman J. Cement retention in revision total hip arthroplasty: filling the hole. Orthopedics. 2008 Sep; 31(9):909-10. PMID: 18814610.
      View in: PubMed
    71. Miyazaki M, Sugiyama O, Tow B, Zou J, Morishita Y, Wei F, Napoli A, Sintuu C, Lieberman J, Wang JC. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Spinal Disord Tech. 2008 Jul; 21(5):372-9. PMID: 18600149.
      View in: PubMed
    72. Lassen MR, Ageno W, Borris LC, Lieberman J, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008 Jun 26; 358(26):2776-86. PMID: 18579812.
      View in: PubMed
    73. Miyazaki M, Sugiyama O, Zou J, Yoon SH, Wei F, Morishita Y, Sintuu C, Virk MS, Lieberman J, Wang JC. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Spine (Phila Pa 1976). 2008 Jun 01; 33(13):1410-7. PMID: 18475244.
      View in: PubMed
    74. Hsu WK, Wang JC, Liu NQ, Krenek L, Zuk PA, Hedrick MH, Benhaim P, Lieberman J. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J Bone Joint Surg Am. 2008 May; 90(5):1043-52. PMID: 18451397.
      View in: PubMed
    75. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9. PMID: 18534438.
      View in: PubMed
    76. Hsu WK, Virk MS, Feeley BT, Stout DB, Chatziioannou AF, Lieberman J. Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET/CT. J Nucl Med. 2008 Mar; 49(3):414-21. PMID: 18287261; PMCID: PMC2678960.
    77. Carofino BC, Lieberman J. Gene therapy applications for fracture-healing. J Bone Joint Surg Am. 2008 Feb; 90 Suppl 1:99-110. PMID: 18292364.
      View in: PubMed
    78. Virk MS, Conduah A, Park SH, Liu N, Sugiyama O, Cuomo A, Kang C, Lieberman J. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone. 2008 May; 42(5):921-31. PMID: 18295562.
      View in: PubMed
    79. Lieberman J, Roth KM, Elsissy P, Dorey FJ, Kobashigawa JA. Symptomatic osteonecrosis of the hip and knee after cardiac transplantation. J Arthroplasty. 2008 Jan; 23(1):90-6. PMID: 18165036.
      View in: PubMed
    80. Soohoo NF, Vyas RM, Samimi DB, Molina R, Lieberman J. Comparison of the responsiveness of the SF-36 and WOMAC in patients undergoing total hip arthroplasty. J Arthroplasty. 2007 Dec; 22(8):1168-73. PMID: 18078886.
      View in: PubMed
    81. Petrigliano FA, Lieberman J. Osteonecrosis of the hip: novel approaches to evaluation and treatment. Clin Orthop Relat Res. 2007 Dec; 465:53-62. PMID: 17906590.
      View in: PubMed
    82. Pariente N, Morizono K, Virk MS, Petrigliano FA, Reiter RE, Lieberman J, Chen IS. A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther. 2007 Nov; 15(11):1973-81. PMID: 17653099.
      View in: PubMed
    83. Richardson JA, Amantea CM, Kianmahd B, Tetradis S, Lieberman J, Hahn TJ, Parhami F. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway. J Cell Biochem. 2007 Apr 01; 100(5):1131-45. PMID: 17031848.
      View in: PubMed
    84. Wang JC, Alanay A, Mark D, Kanim LE, Campbell PA, Dawson EG, Lieberman J. A comparison of commercially available demineralized bone matrix for spinal fusion. Eur Spine J. 2007 Aug; 16(8):1233-40. PMID: 17205237; PMCID: PMC2200779.
    85. Virk MS, Lieberman J. Tumor metastasis to bone. Arthritis Res Ther. 2007; 9 Suppl 1:S5. PMID: 17634144; PMCID: PMC1924520.
    86. Feeley BT, Liu NQ, Conduah AH, Krenek L, Roth K, Dougall WC, Huard J, Dubinett S, Lieberman J. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration. J Bone Miner Res. 2006 Oct; 21(10):1571-80. PMID: 16995812.
      View in: PubMed
    87. Gamradt SC, Abe N, Bahamonde ME, Lee YP, Nelson SD, Lyons KM, Lieberman J. Tracking expression of virally mediated BMP-2 in gene therapy for bone repair. Clin Orthop Relat Res. 2006 Sep; 450:238-45. PMID: 16702923; PMCID: PMC4291079.
    88. Soohoo NF, Sharifi H, Kominski G, Lieberman J. Cost-effectiveness analysis of unicompartmental knee arthroplasty as an alternative to total knee arthroplasty for unicompartmental osteoarthritis. J Bone Joint Surg Am. 2006 Sep; 88(9):1975-82. PMID: 16951114.
      View in: PubMed
    89. Soohoo NF, Vyas S, Manunga J, Sharifi H, Kominski G, Lieberman J. Cost-effectiveness analysis of core decompression. J Arthroplasty. 2006 Aug; 21(5):670-81. PMID: 16877152.
      View in: PubMed
    90. Feeley BT, Conduah AH, Sugiyama O, Krenek L, Chen IS, Lieberman J. In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models. J Orthop Res. 2006 Aug; 24(8):1709-21. PMID: 16788987.
      View in: PubMed
    91. Soohoo NF, Zingmond DS, Lieberman J, Ko CY. Optimal timeframe for reporting short-term complication rates after total knee arthroplasty. J Arthroplasty. 2006 Aug; 21(5):705-11. PMID: 16877157.
      View in: PubMed
    92. SooHoo NF, Lieberman J, Ko CY, Zingmond DS. Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am. 2006 Mar; 88(3):480-5. PMID: 16510811.
      View in: PubMed
    93. Soohoo NF, Zingmond DS, Lieberman J, Ko CY. Primary total knee arthroplasty in California 1991 to 2001: does hospital volume affect outcomes? J Arthroplasty. 2006 Feb; 21(2):199-205. PMID: 16520207.
      View in: PubMed
    94. Lieberman J, Romano PS, Mahendra G, Keyzer J, Chilcott M. The treatment of hip fractures: variations in care. Clin Orthop Relat Res. 2006 Jan; 442:239-44. PMID: 16394767.
      View in: PubMed
    95. Conduah A, Lieberman J. Venous thromboembolic prophylaxis after elective total hip arthroplasty. Clin Orthop Relat Res. 2005 Dec; 441:274-84. PMID: 16331015.
      View in: PubMed
    96. Lee YP, Jo M, Luna M, Chien B, Lieberman J, Wang JC. The efficacy of different commercially available demineralized bone matrix substances in an athymic rat model. J Spinal Disord Tech. 2005 Oct; 18(5):439-44. PMID: 16189457.
      View in: PubMed
    97. Colwell CW, Berkowitz SD, Lieberman J, Comp PC, Ginsberg JS, Paiement G, McElhattan J, Roth AW, Francis CW. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am. 2005 Oct; 87(10):2169-77. PMID: 16203879.
      View in: PubMed
    98. Lieberman J, Hsu WK. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2005 Sep; 87(9):2097-112. PMID: 16140827.
      View in: PubMed
    99. Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, Huard J, Lieberman J. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone. 2006 Feb; 38(2):154-66. PMID: 16126463.
      View in: PubMed
    100. Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman J. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J Bone Miner Res. 2005 Dec; 20(12):2189-99. PMID: 16294272.
      View in: PubMed
    101. Lieberman J. Cemented femoral revision: lest we forget. J Arthroplasty. 2005 Jun; 20(4 Suppl 2):72-4. PMID: 15991136.
      View in: PubMed
    102. Dragoo JL, Lieberman J, Lee RS, Deugarte DA, Lee Y, Zuk PA, Hedrick MH, Benhaim P. Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plast Reconstr Surg. 2005 May; 115(6):1665-73. PMID: 15861072.
      View in: PubMed
    103. Callaghan JJ, Crowninshield RD, Greenwald AS, Lieberman J, Rosenberg AG, Lewallen DG. Symposium: introducing technology into orthopaedic practice. How should it be done? J Bone Joint Surg Am. 2005 May; 87(5):1146-58. PMID: 15866982.
      View in: PubMed
    104. Sugiyama O, An DS, Kung SP, Feeley BT, Gamradt S, Liu NQ, Chen IS, Lieberman J. Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther. 2005 Mar; 11(3):390-8. PMID: 15727935.
      View in: PubMed
    105. Peterson B, Iglesias R, Zhang J, Wang JC, Lieberman J. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting. Spine (Phila Pa 1976). 2005 Feb 01; 30(3):283-9; discussion 289-90. PMID: 15682007.
      View in: PubMed
    106. Gamradt SC, Feeley BT, Liu NQ, Roostaeian J, Lin YQ, Zhu LX, Sharma S, Dubinett SM, Lieberman J. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone. Anticancer Res. 2005 Jan-Feb; 25(1A):107-15. PMID: 15816526.
      View in: PubMed
    107. Peterson B, Zhang J, Iglesias R, Kabo M, Hedrick M, Benhaim P, Lieberman J. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng. 2005 Jan-Feb; 11(1-2):120-9. PMID: 15738667.
      View in: PubMed
    108. Lieberman J, Conduah A, Urist MR. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res. 2004 Dec; (429):139-45. PMID: 15577478.
      View in: PubMed
    109. Lieberman J, Wenger N. New technology and the orthopaedic surgeon: are you protecting your patients? Clin Orthop Relat Res. 2004 Dec; (429):338-41. PMID: 15577506.
      View in: PubMed
    110. Peterson B, Whang PG, Iglesias R, Wang JC, Lieberman J. Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. J Bone Joint Surg Am. 2004 Oct; 86-A(10):2243-50. PMID: 15466734.
      View in: PubMed
    111. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman J, Crystal RG, Hidaka C. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res. 2004 Dec; 19(12):2021-32. PMID: 15537446.
      View in: PubMed
    112. Vangsness CT, Kurzweil PR, Lieberman J. Restoring articular cartilage in the knee. Am J Orthop (Belle Mead NJ). 2004 Feb; 33(2 Suppl):29-34. PMID: 15005298.
      View in: PubMed
    113. Gamradt SC, Lieberman J. Genetic modification of stem cells to enhance bone repair. Ann Biomed Eng. 2004 Jan; 32(1):136-47. PMID: 14964729.
      View in: PubMed
    114. Lieberman J. Core decompression for osteonecrosis of the hip. Clin Orthop Relat Res. 2004 Jan; (418):29-33. PMID: 15043089.
      View in: PubMed
    115. Gamradt SC, Lieberman J. Bone graft for revision hip arthroplasty: biology and future applications. Clin Orthop Relat Res. 2003 Dec; (417):183-94. PMID: 14646716.
      View in: PubMed
    116. Lieberman J. A closed-suction drain was not beneficial in knee arthroplasty with cement. J Bone Joint Surg Am. 2003 Nov; 85-A(11):2257. PMID: 14630869.
      View in: PubMed
    117. Berry DJ, Berger RA, Callaghan JJ, Dorr LD, Duwelius PJ, Hartzband MA, Lieberman J, Mears DC. Minimally invasive total hip arthroplasty. Development, early results, and a critical analysis. Presented at the Annual Meeting of the American Orthopaedic Association, Charleston, South Carolina, USA, June 14, 2003. J Bone Joint Surg Am. 2003 Nov; 85-A(11):2235-46. PMID: 14630860.
      View in: PubMed
    118. Francis CW, Berkowitz SD, Comp PC, Lieberman J, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med. 2003 Oct 30; 349(18):1703-12. PMID: 14585938.
      View in: PubMed
    119. Oakes DA, Lee CC, Lieberman J. An evaluation of human demineralized bone matrices in a rat femoral defect model. Clin Orthop Relat Res. 2003 Aug; (413):281-90. PMID: 12897620.
      View in: PubMed
    120. Dragoo JL, Choi JY, Lieberman J, Huang J, Zuk PA, Zhang J, Hedrick MH, Benhaim P. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res. 2003 Jul; 21(4):622-9. PMID: 12798061.
      View in: PubMed
    121. Davies MR, Lee YP, Lee C, Zhang X, Afar DE, Lieberman J. Use of a SCID mouse model to select for a more aggressive strain of prostate cancer. Anticancer Res. 2003 May-Jun; 23(3B):2245-52. PMID: 12894499.
      View in: PubMed
    122. Wang JC, Kanim LE, Yoo S, Campbell PA, Berk AJ, Lieberman J. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am. 2003 May; 85-A(5):905-11. PMID: 12728043.
      View in: PubMed
    123. Oakes DA, Jackson KR, Davies MR, Ehrhart KM, Zohman GL, Koval KJ, Lieberman J. The impact of the garden classification on proposed operative treatment. Clin Orthop Relat Res. 2003 Apr; (409):232-40. PMID: 12671507.
      View in: PubMed
    124. Lieberman J, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, Urbaniak JR. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect. 2003; 52:337-55. PMID: 12690862.
      View in: PubMed
    125. Lieberman J, Thomas BJ, Finerman GA, Dorey F. Patients' reasons for undergoing total hip arthroplasty can change over time. J Arthroplasty. 2003 Jan; 18(1):63-8. PMID: 12555185.
      View in: PubMed
    126. Park SH, Silva M, Bahk WJ, McKellop H, Lieberman J. Effect of repeated irrigation and debridement on fracture healing in an animal model. J Orthop Res. 2002 Nov; 20(6):1197-204. PMID: 12472229.
      View in: PubMed
    127. Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman J, Webster AK, Whipple JP, Peters GR, Colwell CW. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial. Ann Intern Med. 2002 Oct 15; 137(8):648-55. PMID: 12379064.
      View in: PubMed
    128. Lee YP, Schwarz EM, Davies M, Jo M, Gates J, Zhang X, Wu J, Lieberman J. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model. Cancer Res. 2002 Oct 01; 62(19):5564-70. PMID: 12359769.
      View in: PubMed
    129. Abe N, Lee YP, Sato M, Zhang X, Wu J, Mitani K, Lieberman J. Enhancement of bone repair with a helper-dependent adenoviral transfer of bone morphogenetic protein-2. Biochem Biophys Res Commun. 2002 Sep 27; 297(3):523-7. PMID: 12270126.
      View in: PubMed
    130. Whang PG, Lieberman J. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty. Am J Orthop (Belle Mead NJ). 2002 Sep; 31(9 Suppl):31-6. PMID: 12349893.
      View in: PubMed
    131. Berger F, Lee YP, Loening AM, Chatziioannou A, Freedland SJ, Leahy R, Lieberman J, Belldegrun AS, Sawyers CL, Gambhir SS. Whole-body skeletal imaging in mice utilizing microPET: optimization of reproducibility and applications in animal models of bone disease. Eur J Nucl Med Mol Imaging. 2002 Sep; 29(9):1225-36. PMID: 12418463.
      View in: PubMed
    132. Whang PG, Lieberman J. Low-molecular-weight herapin. J Am Acad Orthop Surg. 2002 Sep-Oct; 10(5):299-302. PMID: 12374480.
      View in: PubMed
    133. Lieberman J, Ghivizzani SC, Evans CH. Gene transfer approaches to the healing of bone and cartilage. Mol Ther. 2002 Aug; 6(2):141-7. PMID: 12161179.
      View in: PubMed
    134. Lieberman J, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am. 2002 Jun; 84-A(6):1032-44. PMID: 12063342.
      View in: PubMed
    135. Puzas JE, O'Keefe RJ, Lieberman J. The orthopaedic genome: what does the future hold and are we ready? J Bone Joint Surg Am. 2002 Jan; 84-A(1):133-41. PMID: 11792791.
      View in: PubMed
    136. Lieberman J, Hawker G, Wright JG. Hip function in patients >55 years old: population reference values. J Arthroplasty. 2001 Oct; 16(7):901-4. PMID: 11607907.
      View in: PubMed